Heart of the Matter
Commentary
‘If this is an emergency, call 911’
Or, don’t even try speaking directly your doctor.
Heart of the Matter
Beta-blocker therapy post AMI
Stick with beta-blocker therapy until evidence shows why not to use it.
Commentary
CMS clinical trials raise cardiac mortality
Health agencies should take their cues from randomized clinical trial designs to avoid unintended consequences.
Heart of the Matter
PCI or CABG in the high-risk patient
The recent report from the SYNTAX trials should give pause to our interventionalist colleagues embarking on multiple angioplasty and stenting...
Heart of the Matter
Medical quality beats patient comfort
Commentary
The new heart failure: A call for new research initiatives
Progress in treating ischemic heart disease has resulted in more patients with heart failure, and we must work to develop more effective heart...
Sponsored Supplement
Best Practices: Nonvalvular Atrial Fibrillation — Profile on an Effective Alternative to Warfarin
Commentary
The end of polypill – statins for everyone
Commentary
New heart failure guidelines
Although the two new heart failure drugs that are the focus of a new guideline update are improvements to the current therapeutic options, the...
Heart of the Matter
Randomized corporate clinical trials
Commentary
